Is There a Microbiome Associated With Poor Growth in Preterm Infants?
1 other identifier
observational
118
1 country
1
Brief Summary
This study evaluates the relationship between growth and stool microbiota in premature infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2018
CompletedFirst Posted
Study publicly available on registry
December 3, 2018
CompletedStudy Start
First participant enrolled
July 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedApril 1, 2025
March 1, 2025
6.5 years
November 29, 2018
March 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
quantitative rT-PCR of stool microbiome
alpha diversity of bacterial groups in normal growth vs. poor growth
8-10 weeks depending on length of stay in NICU
Study Arms (2)
Normal Growth
Require less than or equal to 110 kcal/kg/day to maintain growth curve
Slow Growth
Require more than 110 kcal/kg/day to maintain growth curve
Interventions
Infants will be provided standard of care and given calories required to maintain appropriate growth per unit policies already in place.
Eligibility Criteria
Preterm infants born at less than 28 weeks gestation will be eligible from birth until discharge. Infants with major congenital anomalies which alter growth patterns will be excluded.
You may qualify if:
- All infants less than 28 weeks gestation who are admitted to the Parkland Hospital NICU.
You may not qualify if:
- Infants \>27 weeks gestation. Infants with major congenital anomalies which may alter growth patterns.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Parkland Hopsital and Health System
Dallas, Texas, 75235, United States
Biospecimen
Stool samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Pediatrics
Study Record Dates
First Submitted
November 29, 2018
First Posted
December 3, 2018
Study Start
July 15, 2019
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share